Invention Grant
US07855288B2 Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
失效
吡咯并[1,2-d] [1,2-4]三嗪作为c-Jun N末端激酶(JNK)和p-38激酶的抑制剂
- Patent Title: Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
- Patent Title (中): 吡咯并[1,2-d] [1,2-4]三嗪作为c-Jun N末端激酶(JNK)和p-38激酶的抑制剂
-
Application No.: US11576301Application Date: 2005-10-25
-
Publication No.: US07855288B2Publication Date: 2010-12-21
- Inventor: Qing Dong
- Applicant: Qing Dong
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Hoxie & Associates LLC
- International Application: PCT/US2005/038071 WO 20051025
- International Announcement: WO2006/047354 WO 20060504
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/53 ; A61P19/02 ; A61P1/00
![Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases](/abs-image/US/2010/12/21/US07855288B2/abs.jpg.150x150.jpg)
Abstract:
A compound of formula (I): wherein the substituents are as defined in the specification as inhibitor of C-Jun N terminal Kinases (JNK) and P-38 Kinases.
Public/Granted literature
- US20080253988A1 Pyrrolo [1,2-D] [1,2-4] Triazine as Inhibitors of C-Jun N Terminal Kinases (Jnk) and P-38 Kinases Public/Granted day:2008-10-16
Information query